comparemela.com

Latest Breaking News On - Pharma revenue - Page 1 : comparemela.com

Balaxi Pharmaceuticals Reports Continued Solid Growth in Q1 FY23

Hyderabad, Telangana, India Revenue grows 42% in Q1FY23. ​Pharma Revenue in Latin America up 39%. Profit After Tax up 32% YoY. Balaxi Pharmaceuticals Limited (Balaxi), a branded IPR-based pharmaceutical company headquartered in Hyderabad, reported its results for the first quarter of financial year

They help drive global pharma revenue - Times of India

India Business News: Indegene, a technology services company founded in 1998, focuses on the life sciences industry. Rajesh Nair, Gaurav Kapoor, Anand Kiran, and Sanjay Pa

Operation Food Search Names New Chief Operating Officer

Reply Adams will handle the overall strategic and operational responsibilities of the organization s established programs. (Operation Food Search) Operation Food Search (OFS), a non-profit hunger relief organization, recently hired Carlton Adams as its Chief Operating Officer. He will handle the overall strategic and operational responsibilities of the organization s established programs, which focus on reducing child hunger and family food insecurity. Adams will collaborate with OFS s leadership team to ensure all initiatives and partnerships align with the agency s vision. Adams has 25 years of experience in strategic planning, business development, customer operations and financial management. Prior to joining OFS, he was Acting Executive Director of the National Conference for Community & Justice of Metropolitan St. Louis (NCCJ St. Louis) in addition to serving as its Board President. Adams previous positions include Vice President of Pharma Revenue and Invoicing at Express

Piramal: DHFL aside, pharma to drive Piramal stock

DHFL aside, pharma to drive Piramal stock The pharma division’s growth was hit by the 14 per cent year-on-year drop in the hospital generics business in the first nine months of FY21. Synopsis The company’s management has guided for a 15 per cent organic revenue growth in the pharma business for FY22 compared with the 1 per cent growth in the first nine months of FY21. ET Intelligence Group: The stock of Piramal Enterprises has gained nearly 52 per cent since the beginning of February largely on account of developments in its finance business such as the acquisition of DHFL, entry into retail lending, and recovery in the property market. The stock momentum may sustain given the improving prospects of its pharmaceutical division and a possibility of its demerger and listing in the medium term.

पीरामल एंटरप्राइसेज शेयर प्राइस: एक महीने में 52% उछला पीरामल एंटरप्राइजेज का शेयर, क्या जारी रहेगी तेजी?

पीरामल एंटरप्राइसेज शेयर प्राइस: एक महीने में 52% उछला पीरामल एंटरप्राइजेज का शेयर, क्या जारी रहेगी तेजी?
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.